Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy
Engineered T cell-based adoptive immunotherapies met promising success for the treatment of hematological malignancies. Nevertheless, major hurdles remain to be overcome regarding the management of relapses and the translation to solid tumor settings. …